Jean-Pierre Raynaud

Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients

Jean-Christophe Carraro, Jean-Pierre Raynaud, Gary G. Koch et al. · The Prostate · 1996 · 340 citations

Comparison of a Phytotherapeutic Agent (Permixon) with an α-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: A 1-Year Randomized International Study

F.M.J. Debruyne, Gary G. Koch, Peter Boyle et al. · European Urology · 2002 · 172 citations

Urology, Medicine, Phytotherapeutic Agent +4

Inhibition of type 1 and type 2 5α-reductase activity by free fatty acids, active ingredients of Permixon®

Jean-Pierre Raynaud, Henri Cousse, Pierre-Marie Martin · The Journal of Steroid Biochemistry and Molecular Biology · 2002 · 97 citations

Type 1, Biochemistry, Lipid Nutrition +7

Effect of the Lipidosterolic Extract of Serenoa repens (Permixon<sup>®</sup>) and Its Major Components on Basic Fibroblast Growth Factor-Induced Proliferation of Cultures of Human Prostate Biopsies

M. Paubert-Braquet, Henri Cousse, Jean-Pierre Raynaud et al. · European Urology · 1998 · 73 citations

Serenoa Repens, Urology, Medicine +8